# Triple Combination DAAs for Treating HCV GT1b Subjects

> **NCT02932293** · PHASE2 · WITHDRAWN · sponsor: **Humanity and Health Research Centre**

## Conditions studied

- Chronic Hepatitis C Infection

## Interventions

- **DRUG:** SOF+DCV+SMV

## Key facts

- **NCT ID:** NCT02932293
- **Lead sponsor:** Humanity and Health Research Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The collaborating pharmaceutical company will not wish to continue with the trial due to the internal issues in the company.
- **Last updated:** 2017-05-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02932293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02932293, "Triple Combination DAAs for Treating HCV GT1b Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02932293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*